Zepbound faces unique challenges in Asia-Pacific, including price sensitivity, conservative reimbursement policies, and competition from locally manufactured GLP-1 analogs
Why does berberine take so much longer than a GLP-1 to produce a measurable effect
In addition, these patients are at increased risk of diabetes, hypertension, and hyperlipidemia
The Outcome Reduction with Initial Glargine Intervention trial (i.e., ORIGIN) was an open-label, randomized, 12,537 patient study that compared LANTUS to standard care on the time to first occurrence of a major adverse cardiovascular event (MACE)
24 ] As a side note, when it comes to inborn errors of metabolism and valproic acid, you have to worry about more than just hyperammonemia
PTD-DBM is more narrowly targeted, focused specifically on removing CXXC5 suppression of Wnt signaling